American Financial Group Inc Biogen Inc. Transaction History

American Financial Group Inc

  • $233 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 06, 2021
SELL
$259.0 - $414.71 $906,500 - $1.45 Million
-3,500 Closed
0 $0
Q1 2021

May 11, 2021
SELL
$242.95 - $284.63 $850,325 - $996,205
-3,500 Reduced 50.0%
3,500 $979,000
Q3 2017

Nov 03, 2017
BUY
$281.15 - $329.69 $1.97 Million - $2.31 Million
7,000
7,000 $2.19 Million

Others Institutions Holding BIIB

# of Institutions
1,018
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track American Financial Group Inc Portfolio

Follow American Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email